Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed May 30, 2024

Accession no.
0001415889-24-014888
Filed
May 30, 2024
Trade date
May 28-29, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.93M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 28, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
May 28, 2024Common StockSSaleDisposed−296$267.77F2−$79,259.923,434Direct
May 28, 2024Common StockSSaleDisposed−1,776$268.78F3−$477,353.281,658Direct
May 28, 2024Common StockSSaleDisposed−1,442$269.54F4−$388,676.68216Direct
May 28, 2024Common StockSSaleDisposed−86$271.26F5−$23,328.36130Direct
May 29, 2024Common StockMOption exerciseAcquired+3,600$129.49+$466,1643,730Direct
May 29, 2024Common StockSSaleDisposed−501$265.22F6−$132,875.223,229Direct
May 29, 2024Common StockSSaleDisposed−805$265.97F7−$214,105.852,424Direct
May 29, 2024Common StockSSaleDisposed−1,212$267.59F8−$324,319.081,212Direct
May 29, 2024Common StockSSaleDisposed−1,082$268.35F9−$290,354.7130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 28, 2024Common StockMOption exerciseDisposed−3,600$0.00$0219,869Direct
May 29, 2024Common StockMOption exerciseDisposed−3,600$0.00$0216,269Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $267.195 to $268.185. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $268.195 to $269.185. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $269.25 to $270.055. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $271.15 to $271.375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $264.56 to $265.555. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $265.61 to $266.235. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $266.865 to $267.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $267.895 to $268.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)